Navigation Links
Novo Nordisk Submits First Recombinant Treatment for Factor XIII Deficiency for U.S. Regulatory Approval
Date:2/23/2011

PRINCETON, N.J., Feb. 23, 2011 /PRNewswire/ -- Novo Nordisk announced today that a Biologic License Application (BLA) has been submitted to the U.S. Food and Drug Administration (FDA) requesting the approval of a recombinant factor XIII compound (rFXIII) for the vast majority of patients with congenital factor XIII (FXIII) deficiency, an inherited bleeding disorder(1). The company anticipates filing its marketing authorization application to the European Medicines Agency in Q2 2011.

Currently, FXIII deficient patients are treated with products derived from human blood plasma(2), which carry an inherent risk of contamination. Treatments created using recombinant technology are genetically engineered and not sourced from human blood or plasma. The use of this technology in the development of treatments helps to reduce the potential risk of transmitting blood-borne illnesses.

Patients with congenital FXIII deficiency have a lifelong susceptibility towards bleeding problems, including spontaneous intracranial hemorrhage. Caused by a lack of the protein clotting factor XIII, FXIII congenital deficiency has a prevalence of one case per two million people(2). With an estimated 600 diagnosed patients worldwide, FXIII deficiency is considered one of the rarest bleeding disorders(3).

"Novo Nordisk is committed to serving the bleeding disorder community, and this submission marks a major milestone in the expansion of our product offerings to this patient group," said Eddie Williams, Vice President of Biopharmaceuticals at Novo Nordisk. "The development of a treatment that does not depend on blood products is an important step for the hundreds of patients affected worldwide by congenital FXIII deficiency."

Positive results from a phase 3 trial examining the efficacy and safety of rFXIII for the prevention of bleeds associated with congenital FXIII deficiency showed that when compared to a historic control group of individuals who did not receive
'/>"/>

SOURCE Novo Nordisk
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Novo Nordisk Creates First Mobile Application to Help Doctors Diagnose Bleeding Disorders
2. Novo Nordisk Intends to Appeal Adverse Ruling in Prandin® (repaglinide) Patent Case
3. Reportlinker Adds Novo Nordisk A/S: PharmaVitae Profile
4. Novo Nordisk A/S and Emisphere Technologies, Inc. Announce License Agreement to Develop Oral Formulation of Insulin for Diabetes
5. Novo Nordisk and Chip Ganassi Racing Team Up for 2011 IZOD IndyCar Series
6. Novo Nordisk and Entertainment Industries Council Work Together to Improve Public Education and Awareness about Diabetes Epidemic
7. Novo Nordisk to Invest $73m in Expansion of U.S. Manufacturing Facility
8. Novo Nordisk Inc. Announces Exclusive Agreement With Upsher-Smith Laboratories, Inc. to Market Vagifem® 10 mcg
9. Novo Nordisk Addresses Innovation in Diabetes Care in Second Issue of Industry Resource for Information on Diabetes and Chronic Disease
10. Novo Nordisk Announces Resources to Help Support Kids with Diabetes Attending Summer Camp
11. Novo Nordisk Awards More Than $300,000 in Grants to Support Education and Community Health Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... July 28, 2014 Reportlinker.com announces that ... its catalogue: Portugal Pharmaceuticals and ... http://www.reportlinker.com/p0207141/Portugal-Pharmaceuticals-and-Healthcare-Report-Q3-2014.html Includes 3 ... Faster-than-expected economic growth last quarter has led us ... upwards. As forecast previously, BMI expects ...
(Date:7/28/2014)... Va. , July 28, 2014  Serco ... services, announced the Company has been awarded a ... Support Command (NEMSCOM) and its Deployable Medical Systems.  ... enable medical personnel to provide world-class healthcare to ... operating environment across the globe. The five year ...
(Date:7/28/2014)... 2014  VigeneTech, Inc, in collaboration with BioLegend, ... Analysis Software, an OEM software solution for analysis ... and offers varieties of bead-based multi-analyte immunoassay products ... of VigeneTech,s data analysis software, FCS data files ... reported LEGENDplex™ software is a ...
Breaking Medicine Technology:Portugal Pharmaceuticals and Healthcare Report Q3 2014 2Portugal Pharmaceuticals and Healthcare Report Q3 2014 3Portugal Pharmaceuticals and Healthcare Report Q3 2014 4Serco Awarded $22.7 Million Contract to Support Deployable Medical Systems 2VigeneTech Releases New Powerful Software for Flow Cytometry Data Analysis 2
... VANCOUVER, Oct. 7 /PRNewswire-FirstCall/ - Burcon NutraScience,Corporation ... and,Supertein(TM) canola protein isolates are GRAS (Generally ... a variety of food and beverage,applications. The ... evaluation by a panel of qualified experts ...
... study of adults, VYVANSE taken once-daily significantly,improved the ... Oct. 7 Shire plc (LSE: SHP,Nasdaq: SHPGY), ... study published in the September issue of the ... Deficit Hyperactivity Disorder (ADHD) symptoms in adults within,the ...
Cached Medicine Technology:Burcon announces GRAS status for Puratein(R) & Supertein(TM) 2Burcon announces GRAS status for Puratein(R) & Supertein(TM) 3Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 2Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 3Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 4Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 5Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 6
(Date:7/29/2014)... Boardman, Ohio (PRWEB) July 29, 2014 ... online course designed to teach students how to train ... course, called Certified Behavioral Consultant Trainer , will ... with PeopleKeys Director of Training John Schindell as a ... September 16. , The Certified Behavioral Consultant Trainer ...
(Date:7/29/2014)... Tucson-based company Outski has created a ... and wellness program, called 401(play)™. A 401(play)™ plan promotes ... for employees to use their earned vacation time. In ... the amount of each paycheck to be put into ... offering a 401(play)™ plan to in several ways; for ...
(Date:7/29/2014)... Charlotte (PRWEB) July 29, 2014 The ... 3 organization has announced the appointment of five new ... year the Coalition announced the election of its executive ... Directors, 6 Board members and 2 Physician Advisors. ... The MSA Coalition mission of education, support, advocacy and ...
(Date:7/29/2014)... July 29, 2014 A Forever Recovery ... clients off to a great start and gives them a ... proud sponsor of the National Cherry Festival kickoff concert held ... concert, which was co-sponsored by Miller Lite and in partnership ... the Pepsi Bay Side Music Stage presented by Blue Cross ...
(Date:7/29/2014)... Nuanced Media, a leading digital marketing agency, ... Insurance Portability and Accountability Act) certified firm. HIPAA ... transfer of Personal Health Information (PHI). By obtaining ... can effectively serve their medical industry clients. , The ... medical industry specific products such as medical websites ...
Breaking Medicine News(10 mins):Health News:PeopleKeys Announces New Certified Behavioral Consultant Trainer Course 2Health News:PeopleKeys Announces New Certified Behavioral Consultant Trainer Course 3Health News:Outski launches 401(play)™ Plan to Employers as Part of an Employee Benefit / Health and Wellness Program 2Health News:The Multiple System Atrophy Coalition Appoints Five New Members to Board of Directors 2Health News:The Multiple System Atrophy Coalition Appoints Five New Members to Board of Directors 3Health News:The Multiple System Atrophy Coalition Appoints Five New Members to Board of Directors 4Health News:A Forever Recovery Sponsors National Cherry Festival Kickoff Concert Featuring Collective Soul on July 5 in Traverse City, MI 2Health News:Nuanced Media Web Design Agency Now Hipaa Certified 2
... Ten outstanding clinical research projects from institutions around the ... Research Forum Top 10 Clinical Research Achievement Awards. The ... that results from the nation,s investment in clinical research ... hail from Baylor College of Medicine, the Cleveland Clinic ...
... , WEDNESDAY, April 18 (HealthDay News) -- ... adults, risk of being hospitalized for lung and heart ... Harvard School of Public Health researchers compared air-quality data ... 65 and older admitted to 3,000 New England hospitals ...
... 17 (HealthDay News) -- Pregnant women who are overweight ... for pregnancy complications, a new study shows. These women ... normal blood sugar or those with gestational diabetes and normal ... pregnant women who are obese or have gestational diabetes, and ...
... , TUESDAY, April 17 (HealthDay News) -- A new study ... new kind of radiation treatment, in patients with prostate cancer. ... radiation therapy were more likely to suffer from gastrointestinal side ... be any extra benefit for those who got proton therapy. ...
... , TUESDAY, April 17 (HealthDay News) -- Mothers with ... according to a new study. Pennsylvania State University researchers ... the ages of 1 month and 2 years over 7 ... mothers and their infants, quality of sleep. Greater amounts ...
... HealthDay Reporter , TUESDAY, April 17 (HealthDay News) ... cells led to a nearly 50 percent improvement in survival ... that claimed the life of U.S. Sen. Edward Kennedy, a ... about 40 patients with recurrent glioblastoma -- an aggressive brain ...
Cached Medicine News:Health News:Awards celebrate clinical research that can improve health and alleviate suffering 2Health News:Awards celebrate clinical research that can improve health and alleviate suffering 3Health News:More Smog Might Mean More Hospitalizations 2Health News:Overweight Pregnant Women at Higher Risk for Complications 2Health News:Study Casts Doubt on Value of Pricey Prostate Cancer Therapy 2Health News:Study Casts Doubt on Value of Pricey Prostate Cancer Therapy 3Health News:Depressed Moms May Hinder Babies' Sleep 2Health News:Brain Tumor Vaccine Shows Promise in Early Trial 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: